๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Neoplasms, Endometrial

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Zhengzhou๐Ÿ“ Hangzhou Beijing Tide Pharmaceutical Co., Ltd ยท Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites๐Ÿ“ Birmingham๐Ÿ“ Boston๐Ÿ“ Boston Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting NCT07022483Phase 386 sites๐Ÿ“ Fort Lauderdale๐Ÿ“ Miami๐Ÿ“ Miami Beach Daiichi Sankyo ยท Tests: Trastuzumab Deruxtecan, Chemotherapy A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC) NCT07108270Phase 21 site๐Ÿ“ Jinan GlaxoSmithKline ยท Tests: Dostarlimab, Carboplatin, Paclitaxel a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer NCT06360653NA2 sites๐Ÿ“ Palermo๐Ÿ“ Palermo ARNAS Civico Di Cristina Benfratelli Hospital ยท Tests: Stereotactic Post-operative Radiotherapy for Endometrial Cancer Single cEll pRofiling PErsistaNce To ImmuNothErapy NCT06680739Phase 21 site๐Ÿ“ Barcelona Vall d'Hebron Institute of Oncology ยท Tests: Durvalumab, Tremelimumab Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer NCT05761561NA2 sites๐Ÿ“ New Haven๐Ÿ“ Miami Yale University ยท Tests: Exercise and medical nutrition DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER NCT07690540NA1 site๐Ÿ“ Milan European Institute of Oncology ยท Tests: Prospective exploratory cohort Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors NCT06974110Phase 115 sites๐Ÿ“ Phoenix๐Ÿ“ San Diego๐Ÿ“ Tampa MOMA Therapeutics ยท Tests: MOMA-341, Irinotecan, Immunotherapy Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma NCT05603910Phase 11 site๐Ÿ“ Miami Aaron Wolfson ยท Tests: Lenvatinib, Pembrolizumab, Hypofractionated External Beam Radiation Therapy, High-Dose Rate (HDR) Brachytherapy Performance of SYMMCORAยฎ vs. V-Locยฎ Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy NCT06024109n/a2 sites๐Ÿ“ Frankfurt am Main๐Ÿ“ Manresa Aesculap AG ยท Tests: Closure of the Vaginal Cuff after Total Hysterectomy Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC NCT03463252Phase 2, Phase 31 site๐Ÿ“ Chengdu West China Second University Hospital ยท Tests: Progesterone, Mirenaยฎ, GnRH agonist A Study of BL-B01D1 + Pembrolizumab ยฑ Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer NCT07054567Phase 21 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1, Pembrolizumab, Bevacizumab European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III NCT04504006n/a1 site๐Ÿ“ Essen Dr. Paul Buderath ยท Tests: Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL) A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites๐Ÿ“ Maumee๐Ÿ“ Portland๐Ÿ“ Fairfax TwoStep Therapeutics, Inc. ยท Tests: TS-104 Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Shanghai GV20 Therapeutics ยท Tests: GV20-0251 A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Orlando Iovance Biotherapeutics, Inc. ยท Tests: Lifileucel Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer NCT05647109n/a1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: No intervention Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer NCT06040970Phase 1, Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Sacituzumab, Cisplatin Registry Platform Ovarian and Endometrial Cancer NCT05129969n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG ยท Tests: Physician's choice according to patient's needs. ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort NCT07808164n/a2 sites๐Ÿ“ Hanoi๐Ÿ“ Ho Chi Minh City Tam Anh Research Institute ยท Tests: IHC analysis for ENPP1, cGAS, and FAP expression DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition NCT05770102Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Atezolizumab Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-ฮฑ Positive Endometrial Cancer NCT03832361Phase 21 site๐Ÿ“ New Haven Alessandro Santin ยท Tests: IMGN853 A Study of Ivonescimab in People With Endometrial and Cervical Cancers NCT06925724Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Ivonescimab Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer NCT05051722n/a25 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Miami Mayo Clinic ยท Tests: Vaginal Fluid Collection, Blood Collection A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332Phase 15 sites๐Ÿ“ Ryde๐Ÿ“ Sydney๐Ÿ“ Westmead EtiraRx Australia Pty Ltd ยท Tests: ERX-315
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy